Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America

References

• Archer DF. Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 2010;17:194–203
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3–9
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey. Climacteric 2012;15:36–44
   PubMed Web of Science ®Google Scholar
• Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause 2013;20:1043–8
   PubMed Web of Science ®Google Scholar
• Frank SM, Ziegler C, Kokot-Kierepa M, Maamari R, Nappi RE. Vaginal Health: Insights, Views & Attitudes (VIVA) survey – Canadian cohort. Menopause Int 2013;19:20–7
   PubMedGoogle Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Calle A, et al. Age at menopause in Latin America. Menopause 2006;13:706–12
   PubMed Web of Science ®Google Scholar
• Chedraui P, Blümel JE, Barón G, et al. Impaired quality of life among middle aged women: a multicentre Latin American study. Maturitas 2008;61:323–9
   PubMed Web of Science ®Google Scholar
• Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric 2010;13:419–28
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Barón G, Collaborative Group for Research of the Climacteric in Latin America (REDLINC), et al. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Menopause 2009;16:1139–48
   PubMed Web of Science ®Google Scholar
• Belizán JM, Cafferata LM, Belizán M, et al. Health inequality in Latin America. Lancet 2007;370:1599–600
   PubMed Web of Science ®Google Scholar
• Lora E. Health perceptions in Latin America. Health Policy Plan 2012;27:555–69
   PubMed Web of Science ®Google Scholar
• Castelo-Branco C, Biglia N, Nappi RE, Schwenkhagen A, Palacios S. Characteristics of post-menopausal women with genitourinary syndrome of menopause: implications for vulvovaginal atrophy diagnosis and treatment selection. Maturitas 2015;81:462–9
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Barón G, Collaborative Group for Research of the Climacteric in Latin America (REDLINC), et al. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 2014;17:433–41
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Riquelme R, et al. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels. Menopause 2002;9:377–80
   PubMed Web of Science ®Google Scholar
• Danckers L, Blümel JE, Witis S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC), et al. Personal and professional use of menopausal hormone therapy among gynecologists: a multinational study (REDLINC VII). Maturitas 2016;87:67–71
   PubMed Web of Science ®Google Scholar
• Ojeda E, Monterrosa A, Blümel JE, Escobar-López J, Chedraui P. Severe menopausal symptoms in mid-aged Latin American women can be related to their indigenous ethnic component. Climacteric 2011;14:157–63
   PubMed Web of Science ®Google Scholar
• Legorreta D, Montaño JA, Hernández I, Salinas C, Hernández-Bueno JA. AMEC Research Committee. Age at menopause, motives for consultation and symptoms reported by 40–59-year-old Mexican women. Climacteric 2013;16:417–25
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010;67:233–8
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10:2232–41
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Particco M, Panay N. The REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 2016;91:81–90
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017;24:728–53
   PubMed Web of Science ®Google Scholar
• Krychman M, Graham S, Bernick B, Mirkin S, Kingsberg SA. The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med 2017;14:425–33
   PubMed Web of Science ®Google Scholar
• Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
   PubMedGoogle Scholar
• Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar